Gastroenterology

Our team of GI experts use advanced screening tools, state-of-the-art treatments and innovative technology to evaluate and treat a wide range of gastroenterology disorders and conditions, including:

• Abdominal pain
• Cirrhosis
• Colon polyps
• Constipation
• Crohn's disease
• Diarrhea
• Difficulty swallowing
• Digestive issues
• Diverticulitis
• Drug induced liver injury
• Fatty liver disease
• Fecal incontinence
• Gallbladder disease
• Gallstones
• Gas
• GI Dysmotility
• Heartburn
• Hemorrhoids
• Hepatitis A, B and C
• Hiatal hernia
• Indigestion
• Irritable bowel syndrome (IBS)
• Liver cancer
• Liver disorders
• Liver transplant evaluation and post-transplant care
• Non-alcoholic steatohepatitis (NASH)
• Noncardiac chest pain
• Pancreatic disease
• Pancreatitis
• Pelvic or anorectal dysfunction
• Peptic ulcer disease
• Primary biliary cirrhosis (PBC)
• Rectal bleeding
• Reflux (GERD)
• Ulcerative colitis

In our spacious Endoscopy Suite and procedure rooms in Doylestown Hospital, physicians use the latest technology to diagnose digestive issues. We offer advanced treatments from endoscopy to general gastroenterology, allowing patients to remain close to home for treatment of a variety of gastrointestinal diseases and disorders.

Common procedures include:

• Bravo pH testing
• Colonoscopy
• Endomucosal resection
• Endoscopic retrograde cholangiopancreatography
• Endoscopic Ultrasound (EUS)
• Enteral stenting
• Esophageal and anorectal manometry
• Esophageal dilatation
• Feeding tube placement and removal
• Fibroscan
• Flexible sigmoidoscopy
• Hemorrhoid banding (O’Regan)
• Hydrogen breath testing for bacterial overgrowth
• Infusion center- full-service, in-office, GI infusion
• Manometry (esophageal and anorectal)
• Metabolic Support Services
• Medical Cannabis Certification
• pH impedance testing (24-hour)
• Polypectomy biopsy
• Upper GI endoscopy (EGD)
• Video capsule endoscopy

Colorectal Cancer and Genetic Testing

Doylestown Health's gastroenterology team participates in clinical trials and research to help shape the way gastrointestinal disease is treated.

Active Trials: Not Accepting New Patients

Non-alcoholic Stearotic Hepatitis (NASH, fatty liver) - REGENERATE (NASH)

• Evaluating the impact on NASH with fibrosis of obeticholic acid treatment
• Coordinated by the Doylestown Health Medical Research Department: 215.345.2119 

Moderate to severe Ulcerative Colitis - UNIFI

• Evaluating the safety and efficacy of ustekinumab induction and maintenance therapy in participants with moderately to severely active ulcerative colitis
• Enrolled patients in follow up through February 2020

For more information about Doylestown Health's open trials, visit the U.S. National Institutes of Health's Clinical Trials database.